- 全部删除
您的购物车当前为空
Dihydroberberine 可抑制人类 ether-a-go-go 相关基因 (hERG) 通道并显着降低 Hsp90 表达及其与 hERG 的相互作用,具有抗动脉粥样硬化、抗炎、降血脂和抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Dihydroberberine 可抑制人类 ether-a-go-go 相关基因 (hERG) 通道并显着降低 Hsp90 表达及其与 hERG 的相互作用,具有抗动脉粥样硬化、抗炎、降血脂和抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 315 | In stock | |
| 5 mg | ¥ 745 | In stock | |
| 10 mg | ¥ 1,280 | In stock | |
| 25 mg | ¥ 2,320 | In stock | |
| 50 mg | ¥ 3,190 | In stock | |
| 100 mg | ¥ 4,350 | In stock |
Dihydroberberine 相关产品
| 产品描述 | Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG. |
| 别名 | 二氢小檗碱 |
| 分子量 | 337.37 |
| 分子式 | C20H19NO4 |
| CAS No. | 483-15-8 |
| Smiles | COc1ccc2C=C3N(CCc4cc5OCOc5cc34)Cc2c1OC |
| 密度 | 1.37 g/cm3 at 20℃ |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| 溶解度信息 | DMSO: 3.37 mg/mL (9.99 mM), Sonication is recommended. | |||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.96 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
| ||||||||||||||||
评论内容